新闻

7月 1, 2021

Larry Veal 加入 Frontage Laboratories, Inc. 担任北美销售和营销高级副总裁

Frontage Laboratories, Inc. 宣布任命北美销售和营销高级副总裁 Larry Veal。在这个职位上，Larry 将负责 Frontage 全部服务组合的销售和营销，包括发现、DMPK、生物分析、中央实验室、安全和毒理学、化学、制造和控制以及临床。作为执行领导团队的一员，Larry 将向 Frontage Laboratories 北美总裁 Glenn Washer 汇报，他将与 Frontage 的业务部门密切合作，制定和实施战略，以利用我们广泛的服务来瞄准关键客户群，并利用我们的在科学和卓越运营方面享有盛誉。

Larry has over 35 years in the pharmaceutical and CRO industry working in business development, management, marketing, and new product development. Prior to joining Frontage, Larry served as Vice President of North America Sales for NAMSA, a medical device contract research organization. In this role, Larry oversaw 36 sales-focused employees with a P&L of over $120 million. Prior to NAMSA, Larry was Global Vice President of Sales at ICON Clinical Research’s Commercialization and Late Phase Business Unit.

Larry 在临床研究领域工作了超过 25 年，在此之前，他在制药行业担任过 12 年以上的各种职务，包括罗氏实验室和强生公司等公司的销售、产品开发、培训和管理。

Larry graduated from Augusta University in 1985 with a BBA in Business Administration, emphasis in Marketing. Larry is a member of several industry organizations and has spoken and chaired sessions at multiple conferences including DIA, NCDEU and SCOPE.

Mr. Washer remarked that, “Larry’s joining brings a wealth of experience and expertise which marks our commitment to our customers, our staff and our shareholders to continue to strengthen and mature our organization’s leadership as we aggressively expand our business both organically and through acquisitions. I am confident that Larry will make significant contributions to our continuing success.”